Search Results 2021-2030 of 39152 for Two-phase

  1. Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. C-section - Mayo Clinic

    Abdominal incisions used during C-section. A C-section includes two surgical cuts, called incisions. The first incision is made through the skin on the abdomen.

  3. A Study of GDC-0199 (ABT-199) Plus MabThera/Rituxan (Rituximab) Compared with Bendamustine Plus MabThera/Rituxan (Rituximab) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  4. Ovulation signs: When is conception most likely? - Mayo Clinic

    Fertility typically is highest during the 2 to 3 days around the time that basal temperature rises. A home ovulation test kit also may be helpful. You can ...

  5. Publications - Saranya Chumsri, M.D. - Mayo Clinic

    ... 2-06/NCCTG N063D (Alliance)]. ESMO Open. 2024 Nov ... Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A ...

  6. Neurosciences Clinical Trials - Medical Professionals

    To accomplish this aim CREST-H will add on to the NINDS-sponsored CREST-2 trial (parallel, outcome-blinded Phase ... stage (PAF), and even at a prodromal stage ( ...

  7. Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors - Mayo Clinic

    Also, to establish for future clinical development the recommended Phase 2 dose (RP2D) of Q901 monotherapy when administered via IV infusion QW for 4 weeks and ...

  9. Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    ... Phase 2 dose (RP2D) (Phase 1b) and to evaluate the effectiveness of JNJ-68284528 (Phase 2). Participation eligibility. Participant eligibility includes age ...